Exploring Complement Biology to Improve Antibody-based Therapies for Non-Hodgkin Lymphoma
Among the many types of cancer acknowledged during the month of September is lymphoma, a cancer arising from a...
Among the many types of cancer acknowledged during the month of September is lymphoma, a cancer arising from a...
Last week, the U.S. Food and Drug Administration (FDA) approved a new combination of drugs, formulated together in a...
Today, the American Association for Cancer Research (AACR) released the results of a national survey on American voter’s opinions...
Yiping He, PhD, received the 2014 AACR-Aflac, Inc. Career Development Award for Pediatric Cancer Research to study how medulloblastoma,...
Margaret Foti, PhD, MD (hc), CEO of the American Association for Cancer Research, recently discussed the tremendous potential of...
Guest Post by Barbara A. Conley, MD National Cancer Institute (NCI)
Bladder cancer is the fifth most common cancer in the United States, predominantly affecting men in the later decades...
Team up with AACR Runners for Research to raise awareness and funds for cancer research in our Halloween day...
The deadline to submit a Competitive Letter of Intent for the NextGen Grants for Transformative Cancer Research is Monday,...
Every year, the American Association for Cancer Research (AACR) organizes a robust program of educational workshops for early-career investigators...